Document is current
Any future updates will be listed below
-
Authors
Álvarez-Sánchez, Esther
Carbayo, Álvaro
Valle-Tamayo, Natalia
Muñoz, Laia
Aumatell, Joaquim
Torres, Soraya
Rubio-Guerra, Sara
García-Castro, Jesús
Selma-González, Judit
Alcolea, Daniel
Turon-Sans, Janina
Lleó, Alberto
Illán-Gala, Ignacio
Fortea, Juan
Rojas-García, Ricard
Dols-Icardo, Oriol
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (FI22/00077, PI21/00791, INT21/00073, PI19/01543, FI22/00077)
Global Brain Health Institute (GBHI ALZ UK-21-720973)
Alzheimer’s Association (AACSF-21-850193)
National Institutes of Health (R01 AG056850)
Fundación Española para el Fomento de la Investigación de la Esclerosis Lateral Amiotrófica (Por un mundo sin ELA)
Alzheimer’s Association (AARF-22-924456)
Fondation Jérôme Lejeune (PDC-2023-51; #202307)
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 15 January 2025
First Online: 23 January 2025
Declarations
:
: The study was approved by the ethics committee of Hospital Sant Pau and adhered to the standards for medical research involving humans as recommended by the Declaration of Helsinki. All participants and/or their legal representatives signed the written informed consent.
: Not applicable.
: The authors declare no competing interests.
